ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain MetastasesPriya Kumthekar, Nuhad K. Ibrahim, Shou‐Ching Tang et al.|Clinical Cancer Research|2020Cited by 242
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET TrialStephen Johnston, Samuel A. Jacobs, Peter Barry et al.|Journal of Clinical Oncology|2018Cited by 233